| Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study | JAMA Oncology | 2017 | 2.4K |
| AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both | BMJ, The | 2017 | 2.2K |
| Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 | JAMA - Journal of the American Medical Association | 2017 | 957 |
| Decision aids for people facing health treatment or screening decisions | The Cochrane Library | 2017 | 898 |
| Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2017 | 875 |
| Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial | Lancet, The | 2017 | 815 |
| A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems | Implementation Science | 2017 | 781 |
| CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts | Annals of Internal Medicine | 2017 | 488 |
| CARE guidelines for case reports: explanation and elaboration document | Journal of Clinical Epidemiology | 2017 | 470 |
| Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism | New England Journal of Medicine | 2017 | 397 |
| Angiotensin II for the Treatment of Vasodilatory Shock | New England Journal of Medicine | 2017 | 377 |
| GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research | BMJ, The | 2017 | 365 |
| Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection | New England Journal of Medicine | 2017 | 361 |
| Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial | Lancet Oncology, The | 2017 | 330 |
| Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery | Canadian Journal of Cardiology | 2017 | 330 |
| Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults | Canadian Journal of Cardiology | 2017 | 205 |
| Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma | JAMA - Journal of the American Medical Association | 2017 | 202 |
| Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review | Systematic Reviews | 2017 | 197 |
| GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research | Research Involvement and Engagement | 2017 | 190 |
| The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration | Seminars in Cell and Developmental Biology | 2017 | 188 |
| Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer | Journal of Thoracic Oncology | 2017 | 178 |
| Criteria for selecting implementation science theories and frameworks: results from an international survey | Implementation Science | 2017 | 178 |
| Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial | Lancet Diabetes and Endocrinology,the | 2017 | 177 |
| Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases | American Journal of Gastroenterology | 2017 | 167 |
| Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison | BMC Medicine | 2017 | 160 |
